STRUGGLE FOR. Italian-Polish-Spanish-Uzbek-Vietnamese Expert Forum Position Paper 2023 for better control of classical modifiable risk factors in clinical practice.

Publication Year: 2023

DOI:
10.5603/cj.96912

PMCID:
PMC10713228

PMID:
37987561

Journal Information

Full Title: Cardiol J

Abbreviation: Cardiol J

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Cardiology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
33.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest: Krzysztof J. Filipiak — Adamed, Alfasigma, AstraZeneca, Bausch Health, Boehringer Ingelheim, Krka, Mundipharma, Mylan, Novartis, Pro.Med.Pl, Servier; Vivencio Barrios — Adamed, Amgen, AstraZeneca, Boehringer Ingelheim, Daiichi Sankyo, Eli Lilly, Ferrer International, Menarini, MSD, Novartis, Novo Nordisk, Organon, Pfizer, Recordati, Sanofi-Aventis, Servier, Viatris; Claudio Ferri — Adamed; Khurshid Fozilov — Adamed; Santiago Jesus Freire Castro — Adamed; Ravshanbek Kurbanov — Adamed; Agnieszka Kuzior — Novo Nordisk (scientific and teaching activities); Francisco Javier Martinez-Martin — Adamed, Amgen, Boehringer Ingelheim, Eli Lilly, Menarini, Novo Nordisk (honoraria for advisories, scientific and teaching activities); Guzal Mullabaeva — Novo Nordisk, Pfizer, Servier; Lan Hieu Nguyen — Adamed; Ulugbek Nizamov — Adamed; Anna Tomaszuk-Kazberuk — Adamed, Boehringer Ingelheim, Krka, Novartis, Novo Nordisk, Pfizer, Sanofi, Servier, Takeda; Raisa Trigulova — Adamed; Aleksandra Gąsecka — Abiomed, Adamed, AstraZeneca, Krka, Philips."

Funding Disclosure
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025